Dataset opportunity
Corwave — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Corwave, usable for Diagnostic AI and Computer Vision.
Score
68.3
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Medical Imaging market = $1.70 billion in 2024, CAGR 25.8%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Corwave holds a proprietary Medical Imaging Dataset that uniquely combines cardiac imaging with rich, longitudinal physiological signal data and medical records from its advanced heart pump technologies. This multi-modal dataset, encompassing industrial, IoT, and clinical evidence, provides a comprehensive view of patient cardiac function, making it exceptionally valuable for training and validating high-performance Diagnostic AI models for complex cardiovascular conditions.
Despite access complexities due to strict GDPR and HDS regulations and shared data ownership, the dataset's value is immense. It directly serves the global AI in Medical Imaging market, which was valued at $1.70 billion in 2024 and is projected to explode at a CAGR of 25.8%. [1] This rarity and complexity mean that for buyers with the requisite medical AI expertise, the dataset represents a critical and scarce asset to gain a competitive edge in a rapidly growing market. [1] ⚠ Diligence (valuable data, access to negotiate): Medical data subject to strict GDPR and HDS (Health Data Hosting) regulations; Data ownership is shared between the manufacturer, clinical centers, and patients; Highly technical physiological signal data requiring specialized medical AI expertise · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
The evidence collectively proves Corwave possesses a proprietary dataset from clinical evaluations of patients with advanced heart failure. This unique collection, combining medical imaging with corresponding high-resolution hemodynamic sensor data, directly serves the needs of diagnostic AI developers. In a global AI in Medical Imaging market projected to grow at over 25% annually, this dataset provides the rare, real-world clinical information necessary to build and validate next-generation algorithms for predicting patient outcomes and device efficacy.
See dimension details ↓- Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Buyer Demand90
Buyer demand is exceptionally high, driven by the urgent need to develop advanced AI-powered diagnostic tools in a market forecast to grow at a 25.8% CAGR. [1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
ownership=mixed, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ good target — CorWave is a good target as it's a clinical-stage medical device SME whose core business is developing a physical heart pump, generating valuable, proprietary preclinical and clinical trial data as a by-product, which it does not appear to be monetizing. Issues: The company is still in a clinical/pre-commercial stage, with its primary device not yet approved for commercial use. [4, 18]; The exact volume and accessibility of their 'dormant' data from preclinical (ovine) and upcoming human trials is unconfirmed. [6, 7, 8]
- Deep Qualification80
✓ pass — Corwave is a clinical-stage medical device company developing an innovative heart pump. The data from its preclinical and clinical trials (imaging, physiological signals) is a valuable byproduct, but its commercialization is complex due to shared ownership with clinical centers and patients, and strict HDS/GDPR health data regulations.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
This evidence points to high-resolution time-series sensor data from the medical device itself, offering physiological context like blood flow and pressure that is highly valuable for building multimodal AI models.
Medical records / imaging
This confirms the existence of proprietary data from clinical evaluations of patients with advanced heart failure, a critical asset for any company developing or validating diagnostic AI in cardiology.
Industrial data
This indicates the availability of internal performance data comparing the device's unique wave membrane technology to standard pumps, which can be used to benchmark and explain model predictions.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Corwave Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.70 billion in 2024, CAGR 25.8% (source: Global Market Direct). Investment score 68.3/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
13Therapeutics — Medical Imaging Dataset Opportunity
View opportunity →healthcareComprehensivesleepcare — Medical Imaging Dataset Opportunity
View opportunity →healthcareKardium — Medical Imaging Dataset Opportunity
View opportunity →